Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 36

    1.

    Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.

    Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, Davis RW, Goodson WH.

    Cancer Res. 2008 Apr 1;68(7):2076-80.PMID: 18381411 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Does breast cancer start in the womb?

    Soto AM, Vandenberg LN, Maffini MV, Sonnenschein C.

    Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):125-33. Review.PMID: 18226065 [PubMed - indexed for MEDLINE]Related articles

    3.

    Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.

    Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y.

    Environ Health Perspect. 2008 Jan;116(1):32-8.PMID: 18197296 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons.

    Le HH, Carlson EM, Chua JP, Belcher SM.

    Toxicol Lett. 2008 Jan 30;176(2):149-56. Epub 2007 Nov 19.PMID: 18155859 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma.

    Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H, Tokunaga T, Kawabata S, Kimura M, Shimohigashi Y.

    J Biochem. 2007 Oct;142(4):517-24. Epub 2007 Aug 30.PMID: 17761695 [PubMed - indexed for MEDLINE]Related articles

    6.

    An evaluation of evidence for the carcinogenic activity of bisphenol A.

    Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS.

    Reprod Toxicol. 2007 Aug-Sep;24(2):240-52. Epub 2007 Jun 28. Review.PMID: 17706921 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Bisphenol-A and chlorinated derivatives in adipose tissue of women.

    Fernandez MF, Arrebola JP, Taoufiki J, Navalón A, Ballesteros O, Pulgar R, Vilchez JL, Olea N.

    Reprod Toxicol. 2007 Aug-Sep;24(2):259-64. Epub 2007 Jun 26.PMID: 17689919 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mechanisms of resistance to cisplatin and carboplatin.

    Stewart DJ.

    Crit Rev Oncol Hematol. 2007 Jul;63(1):12-31. Epub 2007 Mar 1. Review.PMID: 17336087 [PubMed - indexed for MEDLINE]Related articles

    9.

    Developmental estrogen exposures predispose to prostate carcinogenesis with aging.

    Prins GS, Birch L, Tang WY, Ho SM.

    Reprod Toxicol. 2007 Apr-May;23(3):374-82. Epub 2006 Oct 24. Review.PMID: 17123779 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption.

    Thomas P, Dong J.

    J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):175-9. Epub 2006 Nov 7.PMID: 17088055 [PubMed - indexed for MEDLINE]Related articles

    11.

    Measurement of bisphenol A concentrations in human colostrum.

    Kuruto-Niwa R, Tateoka Y, Usuki Y, Nozawa R.

    Chemosphere. 2007 Jan;66(6):1160-4. Epub 2006 Aug 14.PMID: 16904728 [PubMed - indexed for MEDLINE]Related articles

    12.

    Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure.

    Welshons WV, Nagel SC, vom Saal FS.

    Endocrinology. 2006 Jun;147(6 Suppl):S56-69. Epub 2006 May 11. Review.PMID: 16690810 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.

    Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P.

    Cancer Res. 2006 Apr 15;66(8):4263-72.PMID: 16618750 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Estrogen-related receptors as emerging targets in cancer and metabolic disorders.

    Ariazi EA, Jordan VC.

    Curr Top Med Chem. 2006;6(3):203-15. Review.PMID: 16515477 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha.

    Long X, Nephew KP.

    J Biol Chem. 2006 Apr 7;281(14):9607-15. Epub 2006 Feb 3.PMID: 16459337 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    LS14: a novel human adipocyte cell line that produces prolactin.

    Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N.

    Endocrinology. 2006 Jan;147(1):306-13. Epub 2005 Sep 29.PMID: 16195405 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-alpha-positive human cells.

    Singleton DW, Feng Y, Yang J, Puga A, Lee AV, Khan SA.

    Environ Res. 2006 Jan;100(1):86-92. Epub 2005 Jul 18.PMID: 16029874 [PubMed - indexed for MEDLINE]Related articles

    18.

    Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens.

    Watson CS, Bulayeva NN, Wozniak AL, Finnerty CC.

    Steroids. 2005 May-Jun;70(5-7):364-71. Epub 2005 Mar 28.PMID: 15862819 [PubMed - indexed for MEDLINE]Related articles

    19.

    PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR.

    Marshall OJ.

    Bioinformatics. 2004 Oct 12;20(15):2471-2. Epub 2004 Apr 8.PMID: 15073005 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.

    Han B, Zhang JT.

    Curr Med Chem Anticancer Agents. 2004 Jan;4(1):31-42. Review.PMID: 14754410 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data